Alnylam Pharmaceuticals
ALNY
#570
Rank
ยฃ31.92 B
Marketcap
ยฃ239.30
Share price
0.26%
Change (1 day)
31.69%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company